LRRK2 Screening in a Canadian Parkinson's Disease Cohort

Canadian Journal of Neurological Sciences - United Kingdom
doi 10.1017/s0317167100006788
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

LRRK2 Pathobiology in Parkinson's Disease

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2014English

Presynaptic Dysfunction in Parkinson's Disease: A Focus on LRRK2

Biochemical Society Transactions
Biochemistry
2012English

Prevalence of the LRRK2 G2019S Mutation in a UK Community Based Idiopathic Parkinson's Disease Cohort

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2006English

Identification of a Japanese Family With LRRK2 p.R1441G-related Parkinson's Disease

Neurobiology of Aging
AgingGerontologyDevelopmental BiologyGeriatricsNeuroscienceNeurology
2014English

LRRK2 Is Not a Significant Cause of Parkinson's Disease in French-Canadians

Canadian Journal of Neurological Sciences
MedicineNeurology
2007English

Rab29 Activation of the Parkinson's Disease‐associated LRRK2 Kinase

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2019English

LRRK2 Is a Component of Granular Alpha-Synuclein Pathology in the Brainstem of Parkinson's Disease

Neuropathology and Applied Neurobiology
Forensic MedicinePathologyNeurologyHistologyPhysiology
2008English

Motor Complications in an Incident Parkinson's Disease Cohort

European Journal of Neurology
Neurology
2015English

Sex and LRRK2 Genotype Differences in Inflammation and Dopaminergic Neurodegeneration in a Multi-Hit Model of Parkinson's Disease

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy